Shannon Yehyawi, MD
Hand Surgery · Columbia, MONPI 1659664225
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 10 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Stryker at 25.8% of the total. Reporting peaked in 2019 at $72 and has fallen 73.5% since, to $19 in 2023. That places this record below the midpoint for hand surgery clinicians in MO, where the typical reported total is $4,263.
Across 10 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$50
- Johnson & Johnson$46
- Endo Pharmaceuticals Inc.$37
- Sanofi-aventis U.S. LLC$19
- Organogenesis Inc.$18
- Medline Industries LP$13
- plus $12 from 1 others
What the payments were for
- Food & beverage$195100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 1 | $50 |
| Johnson & Johnson | 3 | $46 |
| Endo Pharmaceuticals Inc. | 2 | $37 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Organogenesis Inc. | 1 | $18 |
| Medline Industries LP | 1 | $13 |
| Fidia Pharma USA Inc. | 1 | $12 |
How this compares
$195 in reported general payments places this provider in the 10th percentile of 36 hand surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 12 | $284 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $251 |
| Methylprednisolone | 15 | $131 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Columbia
- Jay BridgemanColumbia$40K
- Matthew JonesColumbia$235
- Richard GelbermanSaint Louis$30K
- Tyler KrummenacherSaint Louis$26K
- Wassim MouradSaint Louis$24K
- Georgina GlogovacChesterfield$20K
- Robert BellSaint Louis$20K
- Alexander PalmerLees Summit$12K
- Matthew WintertonSaint Louis$10K
- Nathan FisherSaint Louis$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.